欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	SE/H/0918/002
药品名称	Numeta G16E
活性成分	alanine 4.66 g arginine 4.89 g aspartic acid 3.5 g calcium chloride 2.06 g cysteine 1.1 g glucose monohydrate 550.0 g glutamic acid 5.83 g glycine 2.33 g histidine 2.21 g isoleucine 3.9 g leucine 5.83 g lysine monohydrate 7.2 g magnesium acetate 1.51 g methionine 1.4 g olive oil 0.0 g ornithine hydrochloride 1.85 g phenylalanine 2.45 g potassium acetate 5.05 g proline 1.75 g serine 2.33 g sodium chloride 1.37 g sodium glycerophosphate 4.43 g soybean oil 0.0 g taurine 0.35 g threonine 2.16 g tryptophan 1.17 g tyrosine 0.45 g valine 4.43 g
剂型	Emulsion for infusion
上市许可持有人	Baxter Medical AB Sweden
参考成员国 - 产品名称	Sweden (SE) Numeta G16E
互认成员国 - 产品名称	Germany (DE) NUMETA Ped G 16% E Emulsion zur Infusion Denmark (DK) Numeta Ped G16%E Belgium (BE) Numetzah G16%E émulsion pour perfusion Netherlands (NL) Luxembourg (LU) United Kingdom (Northern Ireland) (XI) Ireland (IE) Austria (AT) Numeta G 16 % E Emulsion zur Infusion France (FR) Spain (ES) Portugal (PT) Italy (IT) Greece (GR) Norway (NO) Czechia (CZ) NUMETA Ped G16%E, Emulsion for infusion Finland (FI) Poland (PL) NUMETA G16% E
许可日期	2010/12/15
最近更新日期	2024/01/16
药物ATC编码	B05BA10 combinations
申请类型	TypeLevel1：Known Active Substance TypeLevel2：Additional Strength/Form TypeLevel3：Fixed combination Art 10b Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final PL \| SE/H/0918/002_Final PLDate of last change:2014/01/15 Final SPC \| SE/H/0918/002_Final SPCDate of last change:2014/01/15 PAR \| SE/H/0918/002_PARDate of last change:2014/01/15
市场状态	Positive